alexa Testosterone Supplementation And Monitoring Practices In HIV-infected Men In A Large Multicenter US Cohort: Results From CNICS
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on HIV/AIDS, STDs, & STIs
October 27-29, 2014 Embassy Suites Las Vegas, USA

Adam B Murphy, Ramona Bhatia and Chad Achenbach
ScientificTracks Abstracts: J AIDS Clin Res
DOI: 10.4172/2155-6113.S1.006
Abstract
Background: Testosterone supplementation in US men is increasing, often without proper indications and monitoring. HIV predisposes to hypogonadism, yet testosterone supplementation practices in HIV-infected (HIV+) men are largely unknown. Methods: We conducted a cohort study of adult HIV+ men engaged in care at 7 sites within the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) from 1996-2011, excluding men on testosterone at cohort entry. We used total and free testosterone data. We calculated testosterone supplementation incidence as number of events per follow-up time (person-years, py) from entry to initial supplementation, loss to follow-up, or death. We assessed factors associated with testosterone supplementation using chi-square and Cox regression. Results: We studied 14,454 men with 75,173 py of follow-up. Mean age was 38y (?9.4), 50% were White, 69% were men who have sex with men (MSM), and 4% ever had AIDS wasting. 70% were on antiretroviral therapy (ART), with mean viral load of 4392 copies/ml and nadir CD4+ T-lymphocyte cell count (CD4) of 286 cells/μl at entry. 1482 (10%) initiated testosterone supplementation at mean age of 45y (?9.0) and rate of 20/1,000 py. In bi variable comparisons, testosterone supplementation was significantly associated with age ≥50y, MSM, AIDS wasting, nadir CD4<200 cells/μl, ART, and White race (all p<0.01). In multivariable analyses, testosterone supplementation was independently associated with age (per decade; HR 1.29, 95% CL1.21-1.38; p<0.01), AIDS wasting (HR 2.13, 95% CL 1.69-2.67; p<0.01), nadir CD4 (per 100 cells/μl; HR 0.96, 95% CL 0.94-0.99; p<0.01), ART (HR 1.21, 95% CL 1.05-1.40; p<0.01), and White race (HR 1.69, 95% CL 1.48-1.92; p<0.01). Presupplementation serum testosterone level was measured in 67% (992/1482), and there was deficiency (total testosterone ≤300 ng/dl) in 36% (360/992). Testosterone levels were measured within 6 months of initiating supplementation in 25% (377/1482). Of men over 40 y who initiated testosterone, 33% had a pre-supplementation prostate specific antigen (PSA) test, and 12% had a PSA test 6 months after initiation. Conclusions: In a large, geographically diverse cohort of HIV+ men, we observed a higher testosterone supplementation rate than that reported in a 2011 general US male population (7.57/1,000py). Pre-supplementation testosterone deficiency and post-supplementation monitoring occurred in only 36% and 25%, respectively, suggesting providers do not commonly follow Endocrine Society Clinical Practice Guidelines in HIV+ men.
Biography
Adam B Murphy is an assistant professor in the Department of Urology at Northwestern University Feinberg School of Medicine. He is an academic urologist with a clinical and research focus on health disparities in prostate cancer. He also investigates the effect of HIV on prostate cancer risk and treatment disparities.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords